Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;41(5):224-6.
doi: 10.4103/0253-7613.58512.

A prospective, observational cohort study to elicit adverse effects of antiretroviral agents in a remote resource-restricted tribal population of Chhattisgarh

Harminder Singh  1 , Navin Dulhani, Pawan Tiwari, Prabhakar Singh, Tiku Sinha
Affiliations

A prospective, observational cohort study to elicit adverse effects of antiretroviral agents in a remote resource-restricted tribal population of Chhattisgarh

Harminder Singh et al. Indian J Pharmacol. 2009 Oct.

Abstract

Objective: To assess the adverse effects of antiretroviral therapy (HAART) and its adherence in HIV-infected patients, in remote and tribal area with restricted resources.

Materials and methods: This was a prospective, observational study carried out at Department of Medicine, Government Medical College, Jagdalpur. A set of questions were asked and adverse drug reactions (ADRs) were recorded for every patient.

Results: 79 HIV positive patients were analyzed. Among them, 68 (86%) had at least one ADR. The mean ADR per patient was 1.64 (+/-1.09). The most common ADR in our study was peripheral neuropathy (20.83%), followed by skin rashes (15.83%). Twenty-one patients (26.58%) had severe (grade-3 and grade-4) ADRs. Female patients had more ADRs (45.71%) than males (11.36%); severe ADRs had a statistically significant positive correlation with sex and CD4 cell count of the patients.

Conclusion: In spite of high ADRs, HAART is the only answer to HIV/AIDS; thus, management requires a highly precise balance between benefits of durable HIV suppression and the risks of drug toxicity to achieve the therapeutic goals, with conventional drugs or with newer less toxic agents.

Keywords: Highly affective antiretroviral therapy; adverse drug reaction; antiretroviral therapy; antitubercular treatment.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. WHO and HIV/AIDS. Available from: http://www.who.int/hiv/en/. (last accessed on 2006 Sep 29)
    1. Palella FJ, Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853–60. - PubMed
    1. Scaling up antiretroviral therapy in resource limited settings guidelines for a public health approach. World Health Organization; 2002. Available from: http://www.who.int/hiv/pub/prev_care/en/ScalingUp_E.pdf. - PubMed
    1. Charlesr F. Antiretroviral agents and treatment of hiv infection. In: Laurence LB, John SL, Keith Parker L, editors. Goodman Gilman's the pharmacological basis of therapeutics. 11th ed. McGraw-Hill: Medical Publishing Division; 2006. pp. 1284–308.
    1. d'Arminio Monforte A, Lepri AC, Rezza G, Pezzotti P, Antinori A, Phillips AN, et al. Insights into the reasons for discontinuation of the first highly active antretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients: Italian cohort of antiretroviral Naïve patients. AIDS. 2000;14:499–507. - PubMed